journal article·2010-07-27

Labile Catalytic Packaging of DNA/siRNA: Control of Gold Nanoparticles “out” of DNA/siRNA Complexes

Alex M. Chen, Oleh Taratula, Dongguang Wei, Hsin-I Yen, Thresia Thomas, T. J. Thomas, Tamara Minko, Huixin He

ACS Nano· Volume 4· Issue 7
Publisher page

Abstract

A novel approach was developed to efficiently package and deliver nucleic acids with low generation polypropylenimine (PPI) dendrimers by using Au nanoparticles as a "labile catalytic" packaging agent. The gold nanoparticles (Au NPs) helped low generation dendrimers to package nucleic acids into discrete nanoparticles but are not included in the final DNA/siRNA complexes. Therefore it becomes possible to eliminate the potential toxic problems associated with Au NPs by selectively removing the Au NPs from the resulting nucleic acid complexes before their delivery to targeted cells. This is a new concept in using inorganic engineered nanoparticles in nucleic acid packaging and delivery applications. Furthermore, compared to the siRNA nanostructures (mainly randomly aggregated nanofibers) fabricated by low generation dendrimer alone (Generation 3), the siRNA nanoparticles packaged using this novel approach (by Au NPs modified with G3 PPI) can be internalized by cancer cells and the delivered siRNAs can efficiently silence their target mRNA. The efficiency of mRNA silencing by this novel approach is even superior to higher generation dendrimers (Generation 5).
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Dendrimers and Hyperbranched Polymers · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Rutgers, The State of New Jersey, Newark, New Jersey 07102

Carl Zeiss SMT, Inc., Peabody, Massachusetts 01960

UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey

Cancer Institute of New Jersey, New Brunswick, New Jersey

Department of Pharmaceutics, Rutgers, The State of New Jersey, Piscataway, New Jersey 08854

References (60)

Show source-provided references
1. Santhakumaran, L. M.; Chen, A.; Pillai, C. K. S.; Thomas, T.; He, H. X.; Thomas, T. J.Nanotechnology in Non-viral Gene Delivery. In Nanofabrication towards Biomedical Applications;Hormes, J., Kumar, C., Leuschner, C., Eds.Wiley-VCH:Germany, 2005; pp253−287.10.1002/3527603476.ch10 ↗
2. Vijayanathan V. · Biochemistry · 2002 · 41 · 1408510.1021/bi0203987 ↗
3. Bessis N. · Gene Ther. · 2004 · 11 · S1010.1038/sj.gt.3302364 ↗
4. Kukowska-Latallo J. F. · Proc. Natl. Acad. Sci, U.S.A. · 1996 · 93 · 489710.1073/pnas.93.10.4897 ↗
5. Dufès C. · Adv. Drug Delivery Rev. · 2005 · 57 · 217710.1016/j.addr.2005.09.017 ↗
6. Boas U. · Chem. Soc. Rev. · 2004 · 33 · 4310.1039/b309043b ↗
7. Samad A. · Curr. Pharm. Des. · 2009 · 15 · 295810.2174/138161209789058200 ↗
8. Ali M. M. · Mol. Pharm. · 2009 · 6 · 140910.1021/mp900040u ↗
9. Tang M. X. · Bioconjugate Chem. · 1996 · 7 · 70310.1021/bc9600630 ↗
10. Dennig J. · Top. Curr. Chem. · 2003 · 2003 · 22710.1007/b11013 ↗
11. Malik N. · J. Controlled Release · 2000 · 65 · 13310.1016/S0168-3659(99)00246-1 ↗
12. Zhang Z. Y. · Bioconjugate Chem. · 2000 · 11 · 80510.1021/bc000018z ↗
13. Hong S. · Bioconjugate Chem. · 2004 · 15 · 77410.1021/bc049962b ↗
14. De Brabander-van den Berg E. M. M. · Angew. Chem. Int. Ed.. · 1993 · 32 · 130810.1002/anie.199313081 ↗
15. Tomalia D. A. · Macromolecules · 1986 · 19 · 246610.1021/ma00163a029 ↗
16. Newkome G. R. · 200110.1002/3527600612 ↗
17. Dennig J. · Rev. Mol. Biotechnol. · 2002 · 90 · 33910.1016/S1389-0352(01)00066-6 ↗
18. Braun C. S. · J. Pharm. Sci. · 2005 · 94 · 42343610.1002/jps.20251 ↗
19. Chen A. · Nanotechnology · 2006 · 17 · 544910.1088/0957-4484/17/21/027 ↗
20. Taratula, O.; Savla, R.; Pandya, I.; Kirkpatrick, P.; He, H. X.; Minko, T.PPI Dendrimers as Potential siRNA Delivery Vehicles for Efficient Cancer Therapy: Structure−Function Relationship.Int. J. Nanotechnol.In press
21. Thomas M. · Proc. Natl. Acad. Sci. U.S.A. · 2003 · 100 · 913810.1073/pnas.1233634100 ↗
22. Radu D. R. · J. Am. Chem. Soc. · 2004 · 126 · 1321610.1021/ja046275m ↗
23. Liu Z. · Nano Res. · 2009 · 2 · 8510.1007/s12274-009-9009-8 ↗
24. Yezhelyev M. V. · J. Am. Chem. Soc. · 2008 · 130 · 900610.1021/ja800086u ↗
25. Cheung, W.; Pontoriero, F.; Taratula, O.; Chen, A. M.; He, H. X.DNA and Carbon Nanotubes as Medicine.Adv. Drug Deliv. Rev.In press.
26. Goodman C. M. · Bioconjugate Chem. · 2004 · 15 · 89710.1021/bc049951i ↗
27. Lewinski L. · Small · 2008 · 4 · 2610.1002/smll.200700595 ↗
28. Pan Y. · Small · 2007 · 3 · 194110.1002/smll.200700378 ↗
29. Bar-Ilan O. · Small · 2009 · 5 · 189710.1002/smll.200801716 ↗
30. Chithrani B. D. · Nano Lett. · 2007 · 7 · 154210.1021/nl070363y ↗
31. Li J. J. · Adv. Mater. · 2008 · 20 · 13810.1002/adma.200701853 ↗
32. Zhang Y.; J · Cancer Lett. · 2007 · 250 · 6310.1016/j.canlet.2006.09.021 ↗
33. Pernodet N. · Small · 2006 · 2 · 76610.1002/smll.200500492 ↗
34. Sun X. · Macromolecules · 2004 · 37 · 710510.1021/ma048847t ↗
35. Sun X. · Macromol. Rapid Commun. · 2003 · 24 · 102410.1002/marc.200300093 ↗
36. Garcia M. E. · Anal. Chem. · 1999 · 71 · 25610.1021/ac980588g ↗
37. Bharali D. J. · Proc. Natl. Acad. Sci, U.S.A. · 2005 · 102 · 1153910.1073/pnas.0504926102 ↗
38. Sandhu K. K. · Bioconjugate Chem. · 2002 · 13 · 310.1021/bc015545c ↗
39. Bhattacharya R. · Nano Lett. · 2004 · 4 · 247910.1021/nl0483789 ↗
40. Park C. · Nanotechnology · 2003 · 14 · L1110.1088/0957-4484/14/9/101 ↗
41. Bleher R. · 200510.1017/S143192760550000X ↗
42. Pantarotto D. · Angew. Chem. · 2004 · 116 · 535410.1002/ange.200460437 ↗
43. Tan W. B. · Biomaterials · 2007 · 28 · 156510.1016/j.biomaterials.2006.11.018 ↗
44. Uprichard S. L. · FEBS Lett. · 2005 · 579 · 599610.1016/j.febslet.2005.08.004 ↗
45. Dykxhoorn D. M. · Annu. Rev. Med. · 2005 · 56 · 40110.1146/annurev.med.56.082103.104606 ↗
46. Sarkar T. · Nucleic Acids Res. · 2005 · 33 · 14310.1093/nar/gki156 ↗
47. Gary D. J. · J. Controlled Release · 2007 · 121 · 6410.1016/j.jconrel.2007.05.021 ↗
48. Li S.-D. · Mol. Pharm. · 2006 · 3 · 57910.1021/mp060039w ↗
49. Li S.-D. · Molecular Ther. · 2008 · 16 · 16310.1038/sj.mt.6300323 ↗
50. Koper G. J. M. · J. Am. Chem. Soc. · 1997 · 119 · 651210.1021/ja970442j ↗
51. van Duijvenbode R. C. · Polymer · 1998 · 39 · 265710.1016/S0032-3861(97)00573-9 ↗
52. Cakara D. · Macromolecules · 2003 · 36 · 420110.1021/ma0300241 ↗
53. Sun J. · Bioorg. Chem. · 1994 · 22 · 31810.1006/bioo.1994.1025 ↗
54. Tokuhisa H. · J. Am. Chem. Soc. · 1998 · 120 · 449210.1021/ja9742904 ↗
55. Sideratou Z. · Langmuir · 2000 · 16 · 176610.1021/la990829v ↗
56. Liu W. · J. Am. Chem. Soc. · 1999 · 121 · 1134510.1021/ja9926156 ↗
57. Nagarajan R. · Macromolecules · 2001 · 34 · 392110.1021/ma0021287 ↗
58. Nagarajan R. · J. Macromol. Sci., Pure. Appl. Chem. · 2001 · 38 · 151910.1081/MA-100108402 ↗
59. Ma Y. F. · J. Am. Chem. Soc. · 2004 · 126 · 709710.1021/ja039621t ↗
60. Park C. · Nanotechnology · 2003 · 14 · L1110.1088/0957-4484/14/9/101 ↗